Stock listing

Frankfurt:ISI Ionis Pharmaceuticals, Inc. Aktie

German listing (Frankfurt) of Ionis Pharmaceuticals, Inc. · home listing NASDAQ:IONS

Follow Ionis Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · FWB:ISI

€26.48 EUR +1.80 (+7.3%)

Close on Nov 16, 2026

Past year -44.4% · daily closes, Nov 17, 2025 – Nov 6, 2026, adjusted for splits
Day range
€26.48 – €26.48 EURNov 16, 2026
Market cap
€4.40B EURAt the close on Nov 16, 2026 · price × 166.2M shares outstanding
52-week range
€26.48 – €74.96 EURLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
Traded on an average day
€14,457 EURMedian day 40 shares · 26 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026
Ionis Pharmaceuticals, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:IONS · Home$28.01 USD-1.05 (-3.6%)4,949,013$29.90$29.93$27.98$29.06Close on Nov 16, 2026
LSE:0JDI$28.55 USD-0.05 (-0.2%)5,070$28.58$30.30$28.00$28.60Close on Nov 16, 2026
Frankfurt:ISI€26.48 EUR+1.80 (+7.3%)—€26.48€26.48€26.48€24.68Close on Nov 16, 2026
Munich:ISI€26.10 EUR+1.15 (+4.6%)—€26.10€26.10€26.10€24.95Close on Nov 16, 2026
Stuttgart:ISI€25.49 EUR-0.82 (-3.1%)—€25.96€26.71€25.49€26.31Close on Nov 16, 2026

Daily closes

Last 3 months, Aug 17, 2026 – Nov 6, 2026 · FWB:ISI · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€34.09-0.957-2.7%€34.09€34.09€34.090
€35.04-0.394-1.1%€35.04€35.04€35.040
€35.44-0.962-2.6%€35.44€35.44€35.4440
€36.40-2.267-5.9%€36.40€36.40€36.400
€38.67-0.459-1.2%€38.67€38.67€38.670
€39.13-0.815-2.0%€39.13€39.13€39.13848
€39.94+0.591+1.5%€39.94€39.94€39.94392
€39.35+0.805+2.1%€39.35€39.35€39.35840
€38.55+0.648+1.7%€38.55€38.55€38.550
€37.90-1.04-2.7%€37.90€37.90€37.9074
€38.94-0.387-1.0%€38.94€38.94€38.94578
€39.32-1.147-2.8%€39.32€39.32€39.32137
€40.47+1.338+3.4%€40.47€40.47€40.470
€39.13+1.151+3.0%€39.13€39.13€39.13137
€37.98-1.042-2.7%€37.98€37.98€37.980
€39.02+1.344+3.6%€39.02€39.02€39.020
€37.68+0.127+0.3%€37.68€37.68€37.68200
€37.55-0.54-1.4%€37.55€37.55€37.550
€38.09-2.194-5.4%€38.69€38.72€37.841,110
€40.29+2.166+5.7%€40.29€40.29€40.2992
€38.12-0.915-2.3%€38.12€38.12€38.1240
€39.04+0.155+0.4%€39.04€39.04€39.0464
€38.88-0.255-0.7%€38.88€38.88€38.880
€39.14+0.442+1.1%€38.95€39.24€38.7443
€38.69-0.525-1.3%€38.69€38.69€38.690
€39.22-0.197-0.5%€39.15€40.13€39.131
€39.42-1.14-2.8%€39.42€39.42€39.420
€40.56+0.078+0.2%€40.56€40.56€40.56581
€40.48+2.178+5.7%€39.94€40.79€39.69120
€38.30-0.028-0.1%€38.30€38.30€38.3059
€38.33+0.03+0.1%€38.50€38.59€38.261,050
€38.30-3.625-8.6%€38.30€38.30€38.300
€41.92+1.809+4.5%€41.10€41.97€41.00757
€40.11+1.53+4.0%€39.45€40.15€38.79152
€38.58-1.994-4.9%€38.81€39.13€38.58165
€40.58+0.562+1.4%€40.58€40.58€40.5840
€40.02-0.63-1.5%€39.08€40.29€38.99819
€40.65-3.617-8.2%€40.65€40.65€40.650
€44.26-2.026-4.4%€44.26€44.26€44.260
€46.29-0.997-2.1%€46.29€46.29€46.290
€47.29-0.379-0.8%€47.29€47.29€47.29142
€47.67-0.676-1.4%€47.67€47.67€47.670
€48.34+2.417+5.3%€48.34€48.34€48.340
€45.92+3.594+8.5%€45.32€46.23€44.67539
€42.33-7.682-15.4%€41.66€42.47€41.56200
€50.01-2.091-4.0%€50.01€50.01€50.01252
€52.10+0.846+1.7%€52.10€52.10€52.100
€51.26-0.255-0.5%€51.26€51.26€51.260
€51.51-0.783-1.5%€51.51€51.51€51.510
€52.30-1.002-1.9%€52.30€52.30€52.301
€53.30-0.493-0.9%€53.30€53.30€53.30650
€53.79-1.982-3.6%€53.79€53.79€53.790
€55.77+1.706+3.2%€54.67€55.99€54.618
€54.07+3.033+5.9%€52.75€54.08€52.5473
€51.03+1.46+2.9%€51.03€51.03€51.030
€49.57-2.271-4.4%€49.57€49.57€49.5778
€51.84+0.915+1.8%€51.84€51.84€51.840
€50.93+0.675+1.3%€50.93€50.93€50.938,713
€50.25+1.043+2.1%€50.25€50.25€50.250
€49.21+1.304+2.7%€49.21€49.21€49.210
Ticker
Frankfurt:ISI
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Ionis Pharmaceuticals (NASDAQ:IONS) Q3 2026 Earnings Call

    Mon, Nov 09, 2026 · 9:00 AM ET

    Watch Transcript
  • Ionis Pharmaceuticals (NASDAQ:IONS) Q2 2026 Earnings Call

    Wed, Jul 29, 2026 · 8:30 AM ET

    Watch Transcript
  • Ionis Pharmaceuticals (NASDAQ:IONS) Q1 2026 Earnings Call

    Wed, Apr 29, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

All Ionis Pharmaceuticals, Inc. news

Financings

  • 0.00% Convertible Senior Notes due 2030

    Nov 13, 2025

    Update: US$700M

    Use of proceeds: Approx. $267.6 million to repurchase $200.0 million of 2026 notes; rest for further 2026 note repurchases or repayment at maturity and general corporate purposes

    Announced Nov 11, 2025 · Update Nov 13, 2025

Read by 6ix AI from the company's releases

Decks

Ionis Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
43 in the last 12 months · 264 in all · newest Nov 17, 2026 · oldest 2019
Calls
27 calls with a replay · 27 with a transcript · latest Nov 9, 2026
Decks
20 decks · latest October 2026

Where Ionis Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:IONS · Home listingNASDAQUnited StatesUSD
gettex:ISIgettexGermanyEUR
Lang & Schwarz:A2ACMZLang & SchwarzGermanyEUR
LS Exchange:A2ACMZLS ExchangeGermanyEUR
BX Swiss:ISIBX SwissSwitzerlandCHF
BMV:IONSBMVMexicoMXN
Milan:1IONSMilanItalyEUR
LSE:0JDILSEUnited KingdomUSD
Frankfurt:ISI · This pageFrankfurtGermanyEUR
Dusseldorf:ISIDusseldorfGermanyEUR
Hamburg:ISIHamburgGermanyEUR
Tradegate:ISITradegateGermanyEUR
BIVA:IONSBIVAMexicoMXN
BOATS:IONSBOATSUnited StatesUSD
Munich:ISIMunichGermanyEUR
Stuttgart:ISIStuttgartGermanyEUR
Hanover:ISIHanoverGermanyEUR
Xetra:ISIXetraGermanyEUR

Log in to ask 6ix AI your own questions about Ionis Pharmaceuticals, Inc.